Toumaz to Exhibit at Embedded World 2011

ToumazToumaz, the leading provider of ultra-low energy wireless telemetry technologies for medical monitoring and internet-connected consumer devices, will be demonstrating its latest ultra-low energy wireless SoC TELRAN at Embedded World 2011 in Germany.

The Embedded World exhibition and conference takes place on 1 - 3 March 2011 at the Exhibition Centre Nürnberg Messe. Embedded World is the World's biggest exhibition of its kind and the meeting place of the international embedded community. The event showcases modern, leading-edge ideas and solutions to global challenges for which engineers and especially the developers of embedded systems bear special responsibility. The accompanying conference is the leading European event for the embedded industry and covers all fields of embedded system development. Toumaz will be exhibiting at the event for the first time and will be located at Stand 367 (Hall 12). On the show floor, attendees will be able to see demonstrations of Toumaz's innovative products, including wireless 3 axis accelerometer using the TZ1053TDK boards at 868MHz.

Toumaz has recently added to its expanding 'Connected Consumer' and Connected Healthcare product portfolio with the launch of TZ1053 TELRAN - an ultra-low energy radio for wireless sensor networks, environmental monitoring and smart metering. The portfolio also includes the SensiumTM vital signs monitoring platform, FENIX DAB+/DAB/FM CMOS RF IC and the XENIF all-in-one internet connected and broadcast audio SoC announced in September 2010.

Embedded World annually attracts 18,350 visitors from 66 countries and continues to grow each year. The event is the top worldwide platform for the industry to exchange ideas and source information at a high level.

Related news articles:

About Toumaz
Toumaz (AIM: TMZ) is pioneering low cost, ultra-low power wireless telemetry technologies for a wide range of markets including medical monitoring and internet-connected consumer devices.

Targeting the healthcare market, Toumaz's licensable smart sensor interface and transceiver platform, Sensium, is a leader in non-intrusive, real-time wireless monitoring of multiple physiological vital signs. Sensium offers the potential to transform medical monitoring and reduce the cost of healthcare by wirelessly connecting individuals to healthcare providers - simply, affordably and unobtrusively. Sensium provides the enabling technology for customers to create complete Body Area Networks based on ultra-low power, ultra-small size body-worn monitors. The Sensium system unlocks new product opportunities across a wide range of healthcare and lifestyle markets, including solutions for hospitals, care homes and telecare settings.

Toumaz also uses its ultra low power expertise to design silicon devices for wireless connectivity and internet-connected consumer products. Toumaz currently supplies FM/DAB radio chips and complete modules to market leaders in the digital radio market.

Toumaz has development centres in Oxford, UK and Taipei City, Taiwan.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...